Microbial Pathogenicity Antigenic Variation & Vaccine Development - PowerPoint PPT Presentation

1 / 62
About This Presentation
Title:

Microbial Pathogenicity Antigenic Variation & Vaccine Development

Description:

Microbial Pathogenicity Antigenic Variation & Vaccine Development Kevin Coombs kcoombs_at_cc.umanitoba.ca Nucleic acid mutation rates Chromosomal DNA 1: 1010 - 1011 DNA ... – PowerPoint PPT presentation

Number of Views:144
Avg rating:3.0/5.0
Slides: 63
Provided by: umanitoba
Category:

less

Transcript and Presenter's Notes

Title: Microbial Pathogenicity Antigenic Variation & Vaccine Development


1
Microbial PathogenicityAntigenic Variation
Vaccine Development
Kevin Coombs kcoombs_at_cc.umanitoba.ca
2
Fields Virology, 2001
3
Kinetics of endogenous immune responses
Biron Sen (2007) Fields Virology, Chapter 9
4
Viral-induced Signaling pathways
Biron Sen (2007) Fields Virology, Chapter 9
5
Summary of innate immune responses
Biron Sen (2007) Fields Virology, Chapter 9
6
Fields Virology, 2001
7
Class I Antigen Processing
Yewdell et al Nature Immunol 3 1019
Nature Reviews Immunology 2 283-291 (2002)
8
Class II Antigen Processing
Nature Reviews Immunology 1 126-134
(2001)CROSS-PRESENTATION IN VIRAL IMMUNITY AND
SELF-TOLERANCE
9
Humoral Immunity
10
What is antigenic variation ?
11
Nucleic acid mutation rates
What contributes to Ag variation ?
  • Chromosomal DNA 1 1010 - 1011
  • DNA virus 1 108 - 109
  • RNA virus 1 104 - 105

12
Implications of high mutation rate
13
Reoviridae
Orthomyxoviridae
Some viruses have segmented genomes Allows
assortment
T1L T2J T3D
14
Segmented Genomes Allow Assortment
X
15
Viruses with Segmented Genomes
Influenza (8 genes) 256 possibilities Rotav
irus (11 genes) 2048 possibilities
16
RNA viruses with segmented genomes have capacity
to generate altered genomes by both random
mutation (where rates are high) and by assortment
In Orthomyxoviridae random mutation leads to
Genetic drift and assortment leads to Genetic
shift
Influenza pandemics generally result from
assortment of human and avian influenza viruses
in a pig mixing vessel which results in new
virus
17
(No Transcript)
18
(No Transcript)
19
Junction adhesion molecule
20
Orthomyxoviridae
SPECIFIC VIRUSES
Current genera
100nm virion Pleomorphic Segmented Genome
(7-8 segments) ss(-) RNA Enveloped
Influenza A Influenza B Influenza
C Thogotovirus Isavirus
21
History and Impact
  • Epidemics documented since 1173 AD
  • 1918 Pandemic Spanish Flu (HINI)
  • - Killed 20 50 Million
  • 1957 Asian Influenza ( H2N2)
  • 1968 Hong Kong Flu (H3N2)
  • 1997 - H5N1 outbreak / 18 infected / 6 die
  • 2004 - ( H5N1) 408 cases so far Avian Flu
    / 254 deaths (WHO, Feb. 18)
  • Yearly Epidemics lead to approx. 2000 deaths in
    Canada, 1M deaths globally

22
Bird Flu
An Introduction and Call to Action Jan 3, 2006
23
Orthomyxoviruses
24
What about Humans?
  • 408 people have become infected
  • 254 have died
  • There have been many more suspected cases not
    tested
  • More humans died in 2006 than in the previous 3
    years combined

Cumulative cases as of Feb. 18, 2009 Total
Cases 408 Total Deaths 254 (WHO
database)
25
H5N1 Compared to 1918 Flu
  • For Both Flu types
  • - the virus came directly from birds
  • - young and healthy make up most fatalities
  • - The human immune system creates
    cytokine storm, filling the
    lungs with fluid
  • The 1918 flu had a Case Fatality Ratio of 2.5
  • H5N1 has a Case Fatality Ratio of 60

26
(No Transcript)
27
B
Noda et al., (2006) Nature 439490
Figure 1. Influenza A/PR/8/34 genetic and
structural organization. A. Gene protein coding
assignments characteristics. B. Virus
structure Top, electron micrograph Bottom,
Diagrammatic cartoon of virion, with proteins
designated as in A, middle column.
28
Phylogeny of Influenza A H and N Genes
Fields Virology, 2007, Chapter 47
29
Fields Virology, 2007, Chapter 48
30
(No Transcript)
31
(No Transcript)
32
CAP SNATCHING
n-n-n-n-n-n-n-n-n
n-n-n-n-n-n-n-n-n
n-n-n-n-n-n Cellular mRNA
A G
n-n-n-n-n-n-n-n-n-n-n-n-
3
n-n-n-n-n-n-n-n-n-n-n-n-
A
4
Viral RNA (-)
n-n-n-n-n-n-n-n-n-n-n-n-
mRNA ()
5
33
  • Mediated by PB2
  • Essential to terminate with a G residue

Viral RNA (-) template
- position 16
  • Mediated by PB1
  • Progeny mRNA ()
  • TL into proteins

34
(No Transcript)
35
Influenza Variation
36
Influenza virus transmission/assortment
37
  • The recurring nature of influenza is due to its
    ability
  • to vary surface antigen expression
  • Antigenic Drift
  • Due to subtle changes of the viral genome
  • Changes antigenic character of H and N
  • Responsible for epidemics
  • Antigenic Shift
  • Due to rearrangement of viral gene segments when
    two different influenza viruses infect the same
    cell
  • Produces major changes in the antigenic nature
  • Responsible for epidemics and pandemics

38
Pico rnaviridae
Very small
30nm non-enveloped icosahedral particles 60
copies each of VP1, VP2, VP3, VP4 Genome 7-8kb
ss() RNA 5 genera Enteroviruses 111
strains(poliovirus)
Rhinoviruses 105(common cold) Hepatovirus
2(hepatitis A) Aphthovirus 8(Foot and
mouth) Cardiovirus 7(Encephalomyocarditis)
39
(No Transcript)
40
Overview of picornavirus life cycle
Baltimore Class IV Cytoplasmic Polyprotein
cleavage All proteins amounts No
glycosylation No splicing RNA replication
through full-length (-) strand
41
Translation and processing of picornavirus
proteins
42
Internal Ribosome Entry Site (IRES)
43
Translation and processing of picornavirus
proteins
44
(No Transcript)
45
Picornavirus receptors
46
(No Transcript)
47
Anther prototypic Class IV ss() RNA virus (ex.
Coronaviridae)
www.microbiologybytes.com
www.microbiologybytes.com
Different Coronavirus transcripts are produced by
differentially transcribed messages The genome
is copied into a full-length (-) copy, from which
various sub-genomic () are transcribed
www.microbiologybytes.com
48
Vaccine Development Considerations
  • Which agents should be targeted ?
  • Who should be vaccinated ?
  • What constitutes a good vaccine ?
  • Live vs Dead

49
(No Transcript)
50
Fields Virology, 2001
51
CDC, 2005
52
CDC, 2005
53
Are all Antibody Responses Good ?
Fields Virology, 2001
54
Fields Virology, 2001
55
(No Transcript)
56
(No Transcript)
57
from Ponnuraj et al., J. Gen. Virol. (2001) 82
2663-74
58
Fields Virology, 2001
59
Polio Eradication Program (WHO)
Year
1988
1997
2003
WHO, 2004
60
news.bbc.co.uk/2/low/africa/3725470.stm
61
Fields Virology, 2001
62
Genetic Relatedness Between Vaccinia Virus and
Variola major Brunham Coombs (1998) CJIDMM
Write a Comment
User Comments (0)
About PowerShow.com